Company research
Health Catalyst, Inc.
CIK 1636422Updated Sep 26, 2026
HCAT price & chart
Loading TradingView…
NASDAQ:HCAT on TradingView ↗About the company
Health Catalyst, Inc. (Nasdaq: HCAT) is a healthcare intelligence company designed to accelerate measurable improvement for health systems across cost, clinical, and consumer performance. Backed by deep domain expertise, proprietary AI-driven technology, and $2.8 billion in documented outcomes, Health Catalyst helps health systems move from data to confident, measurable action.
In the news
Health Catalyst to Participate in Upcoming Investor Conference ↗
Med-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue Yield ↗
Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors News provided by Health Catalyst Dec 02, 2025, 06:59 ET Share this article Share to X Share this article Share to X SALT LAKE CITY , Dec. 2, 2025 /PRNewswire/ -- Health Cataly ↗
Recent filings
4 filing
S-8 filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 5.02, 7.01, 9.01
144 filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 5.02, 7.01, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 502,643,000Source | 858,929,000Source | 701,814,000Source | 752,286,000Source |
| Property, Plant and Equipment, NetUSD | 33,838,000Source | 29,394,000Source | 25,712,000Source | 25,928,000Source |
| GoodwillUSD | 209,073,000Source | 259,759,000Source | 190,652,000Source | 185,982,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 77,678,000Source | 86,052,000Source | 73,384,000Source | 92,189,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 50,814,000Source | 249,645,000Source | 106,276,000Source | 116,312,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 59,128,000Source | 57,182,000Source | 60,290,000Source | 47,970,000Source |
| Assets, CurrentUSD | 169,307,000Source | 465,650,000Source | 393,397,000Source | 427,795,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 14,447,000Source | 16,468,000Source | 15,379,000Source | 16,335,000Source |
| Operating Lease, Right-of-Use AssetUSD | 6,640,000Source | 12,058,000Source | 13,927,000Source | 16,658,000Source |
| Other Assets, NoncurrentUSD | 6,107,000Source | 6,016,000Source | 4,742,000Source | 3,734,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 256,863,000Source | 493,722,000Source | 334,895,000Source | 327,276,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Retained Earnings (Accumulated Deficit)USD | -1,364,646,000Source | -1,186,672,000Source | -1,117,170,000Source | -999,023,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 1,586,000Source | -835,000Source | 33,000Source | -648,000Source |
| Stockholders' Equity Attributable to ParentUSD | 245,780,000Source | 365,207,000Source | 366,919,000Source | 425,010,000Source |
| Liabilities and EquityUSD | 502,643,000Source | 858,929,000Source | 701,814,000Source | 752,286,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 89,573,000Source | 325,850,000Source | 89,034,000Source | 82,510,000Source |
| Operating Lease, Liability, CurrentUSD | 3,779,000Source | 3,614,000Source | 3,358,000Source | 3,434,000Source |
| Accounts Payable, CurrentUSD | 9,363,000Source | 11,433,000Source | 6,641,000Source | 4,424,000Source |
| Operating Lease, Liability, NoncurrentUSD | 14,208,000Source | 16,291,000Source | 17,676,000Source | 18,017,000Source |
| Other Liabilities, NoncurrentUSD | 798,000Source | 154,000Source | 74,000Source | 121,000Source |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | 227,000Source | 155,000Source | 73,000Source | 65,000Source |
| Long-term Debt, Current MaturitiesUSD | 1,627,000Source | 231,182,000Source | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 151,624,000Source | 151,178,000Source | 228,034,000Source | 226,523,000Source |
| Short-term InvestmentsUSD | 44,918,000Source | 142,355,000Source | 211,452,000Source | 247,178,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 27,012,000Source | 40,128,000Source | 55,756,000Source | 72,104,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 1,809,000Source | -4,281,000Source | 13,663,000Source | -788,000Source |
| Deferred Income Tax Expense (Benefit)USD | 81,000Source | 77,000Source | 8,000Source | -4,523,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 731,000Source | 14,559,000Source | -33,080,000Source | -35,270,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 41,114,000Source | 80,277,000Source | 11,392,000Source | 27,846,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 36,193,000Source | -22,902,000Source | 20,293,000Source | -39,021,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 968,000Source | 1,616,000Source | 1,236,000Source | 2,167,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 5,000,000Source | 0Source | 1,808,000Source | 8,393,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -235,782,000Source | 151,746,000Source | 2,730,000Source | -2,613,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -198,831,000Source | 143,369,000Source | -10,036,000Source | -76,915,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 50,814,000Source | 249,645,000Source | 106,276,000Source | 116,312,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 21,949,000Source | 10,119,000Source | 5,750,000Source | 5,750,000Source |
| Income Taxes Paid, NetUSD | 395,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 27,000Source | -34,000Source | 21,000Source | -11,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 27,012,000Source | 40,128,000Source | 55,756,000Source | 72,104,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 3,725,000Source | 3,256,000Source | 1,511,000Source | 1,500,000Source |
| Amortization of Intangible AssetsUSD | 35,500,000Source | 28,700,000Source | 29,600,000Source | 37,200,000Source |
| Capitalized Computer Software, AmortizationUSD | 12,500,000Source | 9,700,000Source | 8,500,000Source | 6,800,000Source |
| Deferred Policy Acquisition Costs, Amortization ExpenseUSD | 3,100,000Source | 2,700,000Source | 2,300,000Source | 2,100,000Source |
| DepreciationUSD | 15,000,000Source | 12,800,000Source | 12,600,000Source | 11,100,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | 0Source |
| General and Administrative ExpenseUSD | 49,559,000Source | 56,817,000Source | 76,559,000Source | 61,701,000Source |
| GoodwillUSD | 209,073,000Source | 259,759,000Source | 190,652,000Source | 185,982,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | 110,223,000Source | — | — | — |
| Goodwill, Impairment LossUSD | 105,386,000Source | 0Source | 0Source | 0Source |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | 4,800,000Source | 0Source | — | — |
| Income Tax Expense (Benefit)USD | 716,000Source | 333,000Source | 356,000Source | -4,280,000Source |
| Net Income (Loss) Attributable to ParentUSD | -177,974,000Source | -69,502,000Source | -118,147,000Source | -137,403,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -177,974,000Source | -69,502,000Source | -118,147,000Source | -137,403,000Source |
| Operating ExpensesUSD | 312,529,000Source | 210,585,000Source | 258,730,000Source | 273,192,000Source |
| Operating Lease, Impairment LossUSD | — | 2,200,000Source | 4,081,000Source | 5,023,000Source |
| Payments of Financing CostsUSD | 0Source | 2,152,000Source | — | — |
| Payments to Acquire InvestmentsUSD | 65,132,000Source | 168,307,000Source | 290,836,000Source | 308,961,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | 0Source | 0Source |
| Proceeds from Issuance of Long-term DebtUSD | 0Source | — | — | — |
| Proceeds from Stock Options ExercisedUSD | 0Source | 169,000Source | 950,000Source | 3,969,000Source |
| Financing Receivable, Credit Loss, Expense (Reversal)USD | 1,503,000Source | 1,202,000Source | 1,821,000Source | 691,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 311,136,000Source | 306,584,000Source | 295,938,000Source | 276,236,000Source |
| Operating Income (Loss)USD | -160,854,000Source | -69,806,000Source | -126,897,000Source | -140,005,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -177,258,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | 716,000Source | 333,000Source | 356,000Source | -4,280,000Source |
| Net Income (Loss) Attributable to ParentUSD | -177,974,000Source | -69,502,000Source | -118,147,000Source | -137,403,000Source |
| Earnings Per Share, BasicUSD per share | -2.55Source | -1.15Source | -2.09Source | -2.56Source |
| Earnings Per Share, DilutedUSD per share | -2.55Source | -1.15Source | -2.09Source | -2.63Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 69,896,134Source | 60,184,920Source | 56,418,397Source | 53,721,702Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 69,896,134Source | 60,184,920Source | 56,418,397Source | 54,079,732Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 35,500,000Source | 28,700,000Source | 29,600,000Source | 37,200,000Source |
| Business Combination, Acquisition Related CostsUSD | 3,000,000Source | 8,000,000Source | 3,500,000Source | 2,300,000Source |
| Capitalized Computer Software, AmortizationUSD | 12,500,000Source | 9,700,000Source | 8,500,000Source | 6,800,000Source |
| Cost of Goods and Service, Excluding Depreciation, Depletion, and AmortizationUSD | 159,461,000Source | 165,805,000Source | 164,105,000Source | 143,049,000Source |
| Current Income Tax Expense (Benefit)USD | 635,000Source | 256,000Source | 348,000Source | 243,000Source |
| Deferred Policy Acquisition Costs, Amortization ExpenseUSD | 3,100,000Source | 2,700,000Source | 2,300,000Source | 2,100,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 50,500,000Source | 41,431,000Source | 42,223,000Source | 48,297,000Source |
| General and Administrative ExpenseUSD | 49,559,000Source | 56,817,000Source | 76,559,000Source | 61,701,000Source |
| Goodwill, Impairment LossUSD | 105,386,000Source | 0Source | 0Source | 0Source |
| Income (Loss) Attributable to Parent, before TaxUSD | -177,258,000Source | -69,169,000Source | -117,791,000Source | -141,683,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -161,556,000Source | — | — | — |
| Interest Income (Expense), Nonoperating, NetUSD | -16,404,000Source | 637,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -177,974,000Source | -69,502,000Source | -118,147,000Source | -137,403,000Source |
| Operating ExpensesUSD | 312,529,000Source | 210,585,000Source | 258,730,000Source | 273,192,000Source |
| Research and Development ExpenseUSD | 49,770,000Source | 57,950,000Source | 72,627,000Source | 75,680,000Source |
| Selling and Marketing ExpenseUSD | 52,477,000Source | 54,387,000Source | 67,321,000Source | 87,514,000Source |
Filing attachments
a2026q2ex991-earningspress.htm · 8-K · 2026-08-06
EX-99.1 2 a2026q2ex991-earningspress.htm EX-99.1 Document Exhibit 99.1 Health Catalyst Reports Second Quarter 2026 Results SALT LAKE CITY, UT, August 6, 2026 - Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended June 30, 2026. “We delivered a very productive second quarter, exceeding the high end of our revenue guidance and the mi…
Read attachment ↗a2026q1ex991-earningspress.htm · 8-K · 2026-05-11
EX-99.1 2 a2026q1ex991-earningspress.htm EX-99.1 Document Exhibit 99.1 Health Catalyst Reports First Quarter 2026 Results SALT LAKE CITY, UT, May 11, 2026 - Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended March 31, 2026. “We delivered solid first quarter results, with revenue and adjusted EBITDA exceeding expectations,” said B…
Read attachment ↗